Polydex Pharmaceuticals Ltd. | Balance Sheet
Fiscal year is February-January. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
410.50
578.40
1,021.70
1,273.80
1,283.80
1,593.70
Total Accounts Receivable
1,127.70
990.60
857.70
1,103.80
1,545.90
1,012
Inventories
1,018.10
978.00
890.60
1,157.60
1,038.00
1,078.80
Other Current Assets
83.20
74.30
65.70
68.60
71.80
71
Total Current Assets
2,639.50
2,621.40
2,835.70
3,603.80
3,939.50
3,755.50
Net Property, Plant & Equipment
3,102.50
3,036.00
2,769.50
3,059.00
3,368.50
3,218.80
Long-Term Note Receivable
20.90
20.90
20.90
20.90
20.90
20.90
Total Assets
5,762.90
5,678.30
5,817.90
6,705.60
7,328.90
7,057.70
ST Debt & Current Portion LT Debt
409.90
415.30
106.80
118.50
101.40
Accounts Payable
496.20
531.10
475.70
443.70
424.80
Income Tax Payable
0.90
4.30
4.00
3.40
0.90
Other Current Liabilities
825.90
683.50
632.50
577.80
393.20
Total Current Liabilities
1,732.90
1,634.10
1,219.00
1,143.30
920.30
Long-Term Debt
892.10
874.40
611.10
521.50
640.10
Deferred Taxes
-
-
191.80
22.00
-
Total Liabilities
2,625.10
2,508.60
1,830.10
1,664.90
1,560.50
Common Equity (Total)
3,122.80
3,154.70
3,972.70
5,025.70
5,753.50
Total Shareholders' Equity
3,137.80
3,169.70
3,987.70
5,040.70
5,768.50
Total Equity
3,137.80
3,169.70
3,987.70
5,040.70
5,768.50
Liabilities & Shareholders' Equity
5,762.90
5,678.30
5,817.90
6,705.60
7,328.90
Preferred Stock (Carrying Value)
15.00
15.00
15.00
15.00
15.00
About Polydex Pharmaceuticals
View Profile
